<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><description>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 21 Feb 2021 23:54:09 +0800</pubDate><image><url>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</url><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>恒瑞、信达、君实、百济，PD-1之战谁能笑到最后？差异化优势如何体现？后来者机会在哪里？</title><link>https://mp.weixin.qq.com/s/HL0BxdZFdXpR3rZPzO-yNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKIoHCPxaNAic8ibtxsicYorkv1ZH9sEyOn5zkQGymrB3zjB3yicKU6348nIiaYc7xcbrHZY6kcSdb2Zwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 21 Feb 2021 19:33:27 +0800</pubDate></item><item><title>348亿元！2020阿斯利康中国业绩持续第一，听王磊说他的取胜之道！</title><link>https://mp.weixin.qq.com/s/HBBbInv8ehmuR17v1HtxHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIDbxgCkoRg4nZGmEfhaZ5ZnmTfYq3eNG5ZB5YXAg9kzK1w5SgyKkmGVA1OY3rqSBib5um7uQdYoEg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 21 Feb 2021 19:33:27 +0800</pubDate></item><item><title>2021必答题：谁为你家未纳入医保新药买单？商保是金主吗？惠民保能否撬动新药支付？如何提升患者支付能力？</title><link>https://mp.weixin.qq.com/s/kAhRJCrusspgXJ1Y29pQww</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIDbxgCkoRg4nZGmEfhaZ5Z7v6riaZDqcHrwIjYVp0MPNuAQoB1tXMEaDrvh60hyzac9NhNvCrkFdw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 20 Feb 2021 19:55:59 +0800</pubDate></item><item><title>投资人视角|医疗装备产业宏图2025规划出台，剑指全球50强</title><link>https://mp.weixin.qq.com/s/WISwvE-_PPBmbSlgfwFU2w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIDbxgCkoRg4nZGmEfhaZ5Z3nUEiaPI8PbezhWupERnAR1ianE6SXcu7iapKYiamtwWFUrEeB9Dd6CictQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 20 Feb 2021 19:55:59 +0800</pubDate></item><item><title>恒瑞医药邹建军：祝贺氟唑帕利荣登《CCR》，期待进一步发掘best-in-class潜质</title><link>https://mp.weixin.qq.com/s/dBlQowOxjnu3DbdU6N1xEQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLKkNz02dvdONcXzV7uSYB42q0k1icJrQmk4cmW2H0B9bJggdvpbhKiacCMKqYe7bt0musicfMlvAoPA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 20 Feb 2021 19:55:59 +0800</pubDate></item><item><title>3天3笔license-in超28亿，涉齐鲁、豪森、华东，传统药企巨头创新转型进入飙速时代！</title><link>https://mp.weixin.qq.com/s/n_gU5V4OxCFmOHB22aNTjA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLKkNz02dvdONcXzV7uSYB4uIciclERmtjvmM3891RzWxsDHA8q4t8lcJVvzUFOb36nzPFyXRCvAmw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 19 Feb 2021 20:23:18 +0800</pubDate></item><item><title>2021中国医药创新100峰会将于4月10日在上海召开</title><link>https://mp.weixin.qq.com/s/8Chr37N6ydBuaXRfLxtEkg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLKkNz02dvdONcXzV7uSYB4uAPfogpSnXSUCLQovhVPEYuib8tS4CrAUjaNP0ZwpBibIdsUGsKzTs7A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 19 Feb 2021 20:23:18 +0800</pubDate></item><item><title>看好你的医保卡！刚刚国务院发布重磅医保政策，规范医疗行为，骗保重罚！</title><link>https://mp.weixin.qq.com/s/3xDSRKZVzXrrKrpnwdvPPQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLKkNz02dvdONcXzV7uSYB4rInuuHYoCRtSDZicjaaSsZCRh8icWpvicQAYwef2Im5l0w3rsTEjG9s4w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 19 Feb 2021 20:23:18 +0800</pubDate></item><item><title>全球药企CEO薪酬PK：AZ年薪1.4亿元，罗氏降底薪，诺华愁年终奖</title><link>https://mp.weixin.qq.com/s/M-LHTxJScI1BabpK14qyUg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJUwUvk2Hq1iaXYnumic5AKe1ricJU7mFWQ2mWRqT91MELAVMe7LbmE3sjYEK6pXd9m2ia22SRwPHpDWw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 18 Feb 2021 22:54:23 +0800</pubDate></item><item><title>蓝鸟“折翼”，177万美元天价药停售，频遭重创的基因疗法未来会好吗？</title><link>https://mp.weixin.qq.com/s/d5h4Ov-6RXc9h-hmGMA3Ew</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJUwUvk2Hq1iaXYnumic5AKe12EBFmTbhE7wgeTSnPTQ4WHU2ia0hcF89icbHBYaHkd0vyfrzMgcPWmAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 18 Feb 2021 22:54:23 +0800</pubDate></item><item><title>泽生周明东：药物创新真正“卡脖子”的是思想与资本的局限</title><link>https://mp.weixin.qq.com/s/4-2WxxLSPpPAKcHhMyiVog</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJxP25vpsoib1uyyHMKm8EhbUZ684mxFKC5FCAjY05VAic5LpRu74nZOnFp2N8DicVUFJlVss6g2p7nA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:07:44 +0800</pubDate></item><item><title>亚盛医药杨大俊：中国创新药企业的征途是全球市场</title><link>https://mp.weixin.qq.com/s/T7MXMP6us9u4hNXG3aRpyQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJxP25vpsoib1uyyHMKm8Ehbr8HUN28iczajd4TFl3jdmcDGdqVyq9eicxYTexYFLURicbVWRmJJiawmBg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:07:44 +0800</pubDate></item><item><title>泽璟盛泽林：License-in模式下未来盈利能力需与分成费用平衡</title><link>https://mp.weixin.qq.com/s/YqNdPNJ1MGYltjBGC1_JGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJxP25vpsoib1uyyHMKm8EhbKFTfNIfS2u6UuOiaILDAHcJJ0icDOpg3K63xQMWNKJsmRe0cJ1EEHN2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:07:44 +0800</pubDate></item><item><title>2月21日邀您免费观看2021中国医药产业新年展望会·线上深度版</title><link>https://mp.weixin.qq.com/s/lKIirc2AG8ow2ymUBBs18A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIlXJAqLB13vVplXWCLZFpKRaiaGQpLiaN2ibpdxjJJqhHtqicwPoBmMAo2wYmFSDN5hMMMf2WcnpRGDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:07:44 +0800</pubDate></item><item><title>征集丨医药人的声音！</title><link>https://mp.weixin.qq.com/s/wEJIjGHVASDnbs4rjvAdoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeInqBqHnlP5uCYMiasJIh34WbicWOz1rpMVSH86p2GCPibv7Vsibe8SxXOHzicibAvtD20Ps0HTVicpNjN1A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:07:44 +0800</pubDate></item><item><title>信达刘勇军：新药临床转化效率与策略决定其上市进度与商业价值</title><link>https://mp.weixin.qq.com/s/o-D52dHWQft96iGlE8dkcg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95zFYgibbD0iaqxZGO66OOwXRYzPJoU0qndf80MYSKQrz2YZR0UdDEWcMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>康宁杰瑞徐霆：真正“卡脖子”底层技术有很多没有解决，从关键试剂耗材到核心装备……</title><link>https://mp.weixin.qq.com/s/1NpndHLNHaC0e1bxXNxOrQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95W1NT96U73gp6IqsT2sg0VRnt8gibUTC17HqTcfajl2Q4BPGLR0jDKwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>和黄苏慰国：中国创新药公司真正走向国际市场要拿得出过硬的产品</title><link>https://mp.weixin.qq.com/s/QPZ1b6DFS0y8z1nsd6cd3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl957qiaic8zOafxYMUov2s7fJUlicTjpoOQKqqvUJWWbrsm6MWfqpbibbLzUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>荣昌房健民：走向First-in-class必须有一个有利于原始创新的新药研发环境</title><link>https://mp.weixin.qq.com/s/4JWs2Z3jyXNZbepwMvUM-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95ncUiazjWneTgDwEibqsSEwEWibVTaQQn8ibBE2SWiaY3qibZXiaCAskPIAfNA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>优卡迪俞磊：“原创药”专利是创新药企亟需突破的关键，而资金、良好的竞争机制和创新药的生态环境，是助推的必要条件</title><link>https://mp.weixin.qq.com/s/vc7CvAgGiINGuHZ4By5eYQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95vNDpzMXmT5zuD3jyODH2ODAY3IcaVHyCXTRL5ca4L5iaFYibC8wUrzIQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item></channel></rss>